By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of therapeutics.28.94M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
China14.96M51.68%
United States (U.S.)13.98M48.32%